![](/img/cover-not-exists.png)
Natalizumab for Achieving Relapse-Free, T1 Gadolinium-Enhancing-Lesion-Free, and T2 Lesion-Free Status in Japanese Multiple Sclerosis Patients: A Phase 2 Trial Subanalysis
Saida, Takahiko, Kira, Jun-Ichi, Kishida, Shuji, Yamamura, Takashi, Ohtsuka, Nobuhisa, Dong, Qunming, Tibung, J. T.Volume:
6
Language:
english
Journal:
Neurology and Therapy
DOI:
10.1007/s40120-016-0062-4
Date:
June, 2017
File:
PDF, 516 KB
english, 2017